WPRIM Management System> DCMS> Journal of Gynecologic Oncology> 2022> 33> 3

Volume: 33 Issue: 3

1. Emergency craniotomy: a life-saving procedure as part of multi-modal therapy of GTN Page:e52—
2. Reducing distal pancreatectomy by posterolateral approach for splenectomy in the surgical management of ovarian cancer Page:e48—
3. Molecular classification of endometrial cancer: entering an era of precision medicine Page:e47—
4. PARP inhibitors in ovarian cancer: overcoming resistance with combination strategies Page:e44—
5. Laparoscopic resection surgery for malignant transformation of extragonadal endometriosis by the “pincer” approach Page:e34—
6. Posterior pelvic exenteration, a crucial component in the surgeon’s toolbox for optimizing surgical cytoreduction for advanced ovarian cancer Page:e41—
7. Posterior pelvic exenteration for ovarian cancer: surgical and oncological outcomes Page:e31—
8. Oncologic outcomes according to the level of disease burden in patients with metachronous distant metastases from uterine cervical cancer: a Korean Radiation Oncology Group study (KROG 18-10) Page:e32—
9. Significance of histology and nodal status on the survival of women with early-stage cervical cancer: validation of the 2018 FIGO cervical cancer staging system Page:e26—
10. Clinicopathological and molecular characterization of high-grade endometrial carcinoma with POLE mutation: a single center study Page:e38—
11. Genomic landscape of advanced endometrial cancer analyzed by targeted next-generation sequencing and the cancer genome atlas (TCGA) dataset Page:e29—
12. Treatment and outcomes in undifferentiated and dedifferentiated endometrial carcinoma Page:e25—
13. Effectiveness of craniotomy and long-term survival in 35 patients with gestational trophoblastic neoplasia with brain metastases: a clinical retrospective analysis Page:e33—
14. Predictors of postoperative pancreatic fistula after splenectomy with or without distal pancreatectomy performed as a component of cytoreductive surgery for advanced ovarian cancer Page:e30—
15. Prognostic value of complete metabolic response on 18F-FDG-PET/CT after three cycles of neoadjuvant chemotherapy in advanced high-grade serous ovarian cancer Page:e28—
16. Clinicopathologic and protein markers distinguishing the “polymerase epsilon exonuclease” from the “copy number low” subtype of endometrial cancer Page:e27—
17. HPV vaccination among seropositive, DNA negative cohorts: a systematic review & meta-analysis Page:e24—

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.